Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2392172
Max Phase: Preclinical
Molecular Formula: C17H8BrCl2NO5
Molecular Weight: 457.06
Molecule Type: Small molecule
Associated Items:
ID: ALA2392172
Max Phase: Preclinical
Molecular Formula: C17H8BrCl2NO5
Molecular Weight: 457.06
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1
Standard InChI: InChI=1S/C17H8BrCl2NO5/c18-8-4-9-13(22)6-14(17(24)25)26-15(9)12(5-8)21-16(23)7-1-2-10(19)11(20)3-7/h1-6H,(H,21,23)(H,24,25)
Standard InChI Key: YEAMBSPSKUHTDZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 457.06 | Molecular Weight (Monoisotopic): 454.8963 | AlogP: 4.81 | #Rotatable Bonds: 3 |
Polar Surface Area: 96.61 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.20 | CX Basic pKa: | CX LogP: 4.37 | CX LogD: 0.84 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.59 | Np Likeness Score: -0.88 |
1. Funke M, Thimm D, Schiedel AC, Müller CE.. (2013) 8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35., 56 (12): [PMID:23713606] [10.1021/jm400587g] |
2. Thimm D, Funke M, Meyer A, Müller CE.. (2013) 6-Bromo-8-(4-[(3)H]methoxybenzamido)-4-oxo-4H-chromene-2-carboxylic Acid: a powerful tool for studying orphan G protein-coupled receptor GPR35., 56 (17): [PMID:23888932] [10.1021/jm4009373] |
Source(1):